Dual-component blend: GHRH-R agonist (CJC-1295, Modified GRF 1-29) + GHSR-1a agonist pentapeptide (Ipamorelin) The pathways CJC / IPA Blend acts on and what each one does
Two 2013 systematic reviews of interventions concluded that the modest benefit of propionyl-L-carnitine on walking performance was equivalent or superior to that obtained with drugs approved for claudication in the US (e.g., pentoxyphylline, cilostazol) yet inferior to improvements seen with supervised exercise interventions (69, 70)
In one example of a physiological response to osmotic pressure, in early mammary gland milk production osmoregulatory pathways are exploited using asymmetric kinetics to increase the carnitine concentration in milk for suckling neonates who have reduced carnitine stores, even though this results in decreased maternal liver stores [20]
However, effectiveness depends entirely on whether you're also exercising regularly and maintaining a calorie deficit
:
It is also a stable form of carnitine and does not easily degrade